These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2511695)

  • 1. In vivo actions of organic nitrates on platelet function in humans.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Mazzone A; Lombardi M
    Z Kardiol; 1989; 78 Suppl 2():56-60; discussion 64-7. PubMed ID: 2511695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.
    De Caterina R; Giannessi D; Bernini W; Mazzone A
    Thromb Haemost; 1988 Apr; 59(2):207-11. PubMed ID: 3291182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for the in vivo antiplatelet effects of isosorbide dinitrate.
    De Caterina R; Giannessi D; Mazzone A; Bernini W
    Eur Heart J; 1988 Jan; 9 Suppl A():45-9. PubMed ID: 2457501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentration and hemodynamic effects.
    De Caterina R; Lombardi M; Bernini W; Mazzone A; Giannessi D; Moscarelli E; Weiss M; Lazzerini G
    Am Heart J; 1990 Apr; 119(4):855-62. PubMed ID: 2321506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
    Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
    Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isosorbide dinitrate inhibits in vitro platelet aggregation at submicromolar concentrations].
    Gachet C; Guillou J; Moog S; Cazenave JP
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():61-5. PubMed ID: 1326933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evidence of an endothelial cell-dependent antiplatelet activity for isosorbide dinitrate, but not for its 2- and 5-mononitrate metabolites.
    Rolland PH; Berenger FP; Cano JP
    J Pharmacol Exp Ther; 1987 Jan; 240(1):234-40. PubMed ID: 3100769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
    Davì G; Cannizzaro S; Giubilato A; Novo S; Mattina A; Strano A
    Z Kardiol; 1986; 75 Suppl 3():80-2. PubMed ID: 3541421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of coronary vascular PGI2 by organic nitrates.
    Schrör K; Ahland B; Weiss P; König E
    Eur Heart J; 1988 Jan; 9 Suppl A():25-32. PubMed ID: 3137069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet effects of isosorbide dinitrate in man.
    De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
    Z Kardiol; 1983; 72 Suppl 3():46-51. PubMed ID: 6666233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrates and endothelial prostacyclin production: studies in vitro.
    De Caterina R; Dorso CR; Tack-Goldman K; Weksler BB
    Circulation; 1985 Jan; 71(1):176-82. PubMed ID: 3917245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of isosorbide dinitrate and isosorbide-5-mononitrate on prostacyclin (PGI2) and thromboxane A2 (TXA2) generation in rat and human arteries.
    Nakabayashi S; Uyama O; Nagatsuka K; Uehara A; Wanaka A; Yoneda S; Kimura K; Kamata T
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):323-32. PubMed ID: 3887528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.
    Rolland PH; Bory M; Leca F; Sainsous J; Gueydon E; Juhan I; Serradimigni A; Cano JP
    Prostaglandins Leukot Med; 1984 Dec; 16(3):333-46. PubMed ID: 6396656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.
    Wallén NH; Larsson PT; Bröijersén A; Andersson A; Hjemdahl P
    Br J Clin Pharmacol; 1993 Feb; 35(2):143-51. PubMed ID: 8443032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet function by injectable isosorbide dinitrate.
    De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
    Am J Cardiol; 1984 Jun; 53(11):1683-7. PubMed ID: 6428211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of isosorbide dinitrate on whole blood aggregation].
    Yoshimoto H; Suehiro A; Higasa S; Seto T; Oku KI; Kakishita E
    J Cardiol; 1997 Apr; 29(4):195-201. PubMed ID: 9127835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
    Gerzer R; Karrenbrock B; Niederreiter B; Heim JM; Drummer C
    Z Kardiol; 1991; 80 Suppl 5():9-11. PubMed ID: 1776339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
    Gerzer R; Drummer C; Karrenbrock B; Heim JM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombogenic endothelial cell defense. Basal characteristics in cultured endothelial cells and modulation by short-term and long-term exposure to isosorbide nitrates.
    Berenger FP; Cano JP; Rolland PH
    Circ Res; 1987 Apr; 60(4):612-20. PubMed ID: 3594743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effects of a novel antianginal agent, nicorandil.
    Jaraki O; Strauss WE; Francis S; Loscalzo J; Stamler JS
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):24-30. PubMed ID: 7511731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.